Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMC Pharmacology & Toxicology|April 29, 2016
Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)Nikolaj Kunøe, Arild Opheim, Kristin Klemmetsby Solli, et al.
JAMA Psychiatry|December 20, 2018
Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up StudyZill-E-Huma Latif, Jurate Šaltyte Benth, Kristin Klemmetsby Solli, et al.
JAMA Psychiatry|October 20, 2017
Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority TrialLars Tanum, Kristin Klemmetsby Solli, Zill-E-Huma Latif, et al.
The American Journal on Addictions|February 1, 2019
No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up studyZill-E-Huma Latif, Kristin K Solli, Arild Opheim, et al.
Addiction (Abingdon, England)|May 29, 2018
Effectiveness, safety and feasibility of extended-release naltrexone for opioid dependence: a 9-month follow-up to a 3-month randomized trialKristin Klemmetsby Solli, Zill-E-Huma Latif, Arild Opheim, et al.
European Addiction Research|July 20, 2016
Interest in Extended Release Naltrexone among Opioid UsersKamni Sharma Haase, Nikolaj Kunøe, Arild Opheim, et al.
European Addiction Research|July 25, 2019
Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical TrialKristin Klemmetsby Solli, Nikolaj Kunoe, Zill-E-Huma Latif, et al.
Pageof 1